37 related articles for article (PubMed ID: 27628597)
21. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
[TBL] [Abstract][Full Text] [Related]
22. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
[TBL] [Abstract][Full Text] [Related]
23. LRIG inhibitors of growth factor signalling - double-edged swords in human cancer?
Hedman H; Henriksson R
Eur J Cancer; 2007 Mar; 43(4):676-82. PubMed ID: 17239582
[TBL] [Abstract][Full Text] [Related]
24. LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor.
Ji Y; Kumar R; Gokhale A; Chao HP; Rycaj K; Chen X; Li Q; Tang DG
Semin Cancer Biol; 2022 Jul; 82():120-133. PubMed ID: 33476721
[TBL] [Abstract][Full Text] [Related]
25. Harnessing LRIG1-mediated inhibition of receptor tyrosine kinases for cancer therapy.
Neirinckx V; Hedman H; Niclou SP
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):109-116. PubMed ID: 28259645
[TBL] [Abstract][Full Text] [Related]
26. LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers.
Malik U; Javed A
Curr Cancer Drug Targets; 2017; 17(1):3-16. PubMed ID: 27628597
[TBL] [Abstract][Full Text] [Related]
27. LRIG and cancer prognosis.
Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
[TBL] [Abstract][Full Text] [Related]
28. The LRIG family: enigmatic regulators of growth factor receptor signaling.
Simion C; Cedano-Prieto ME; Sweeney C
Endocr Relat Cancer; 2014; 21(6):R431-43. PubMed ID: 25183430
[TBL] [Abstract][Full Text] [Related]
29. LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications.
Mao F; Wang B; Xiao Q; Cheng F; Lei T; Guo D
J Neurol Sci; 2017 Dec; 383():56-60. PubMed ID: 29246624
[TBL] [Abstract][Full Text] [Related]
30. HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
Herdenberg C; Hedman H
Stem Cell Rev Rep; 2023 Jan; 19(1):59-66. PubMed ID: 35969315
[TBL] [Abstract][Full Text] [Related]
31. LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor.
Wang Y; Poulin EJ; Coffey RJ
Br J Cancer; 2013 May; 108(9):1765-70. PubMed ID: 23558895
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
